BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 9883727)

  • 1. Neurological illness in transgenic mice expressing a prion protein with an insertional mutation.
    Chiesa R; Piccardo P; Ghetti B; Harris DA
    Neuron; 1998 Dec; 21(6):1339-51. PubMed ID: 9883727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary myopathy and accumulation of PrPSc-like molecules in peripheral tissues of transgenic mice expressing a prion protein insertional mutation.
    Chiesa R; Pestronk A; Schmidt RE; Tourtellotte WG; Ghetti B; Piccardo P; Harris DA
    Neurobiol Dis; 2001 Apr; 8(2):279-88. PubMed ID: 11300723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A transgenic model of a familial prion disease.
    Harris DA; Chiesa R; Drisaldi B; Quaglio E; Migheli A; Piccardo P; Ghetti B
    Arch Virol Suppl; 2000; (16):103-12. PubMed ID: 11214912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of protease-resistant prion protein (PrP) and apoptosis of cerebellar granule cells in transgenic mice expressing a PrP insertional mutation.
    Chiesa R; Drisaldi B; Quaglio E; Migheli A; Piccardo P; Ghetti B; Harris DA
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5574-9. PubMed ID: 10805813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A murine model of a familial prion disease.
    Harris DA; Chiesa R; Drisaldi B; Quaglio E; Migheli A; Piccardo P; Ghetti B
    Clin Lab Med; 2003 Mar; 23(1):175-86. PubMed ID: 12733431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prion protein with an octapeptide insertion has impaired neuroprotective activity in transgenic mice.
    Li A; Piccardo P; Barmada SJ; Ghetti B; Harris DA
    EMBO J; 2007 Jun; 26(11):2777-85. PubMed ID: 17510630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple biochemical similarities between infectious and non-infectious aggregates of a prion protein carrying an octapeptide insertion.
    Biasini E; Medrano AZ; Thellung S; Chiesa R; Harris DA
    J Neurochem; 2008 Mar; 104(5):1293-308. PubMed ID: 18034781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant PrPSc conformers induced by a synthetic peptide and several prion strains.
    Tremblay P; Ball HL; Kaneko K; Groth D; Hegde RS; Cohen FE; DeArmond SJ; Prusiner SB; Safar JG
    J Virol; 2004 Feb; 78(4):2088-99. PubMed ID: 14747574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prion protein with an insertional mutation accumulates on axonal and dendritic plasmalemma and is associated with distinctive ultrastructural changes.
    Jeffrey M; Goodsir C; McGovern G; Barmada SJ; Medrano AZ; Harris DA
    Am J Pathol; 2009 Sep; 175(3):1208-17. PubMed ID: 19700753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice.
    Yoshioka M; Imamura M; Okada H; Shimozaki N; Murayama Y; Yokoyama T; Mohri S
    Microbiol Immunol; 2011 May; 55(5):331-40. PubMed ID: 21362027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel PRNP-P105S mutation associated with atypical prion disease and a rare PrPSc conformation.
    Tunnell E; Wollman R; Mallik S; Cortes CJ; Dearmond SJ; Mastrianni JA
    Neurology; 2008 Oct; 71(18):1431-8. PubMed ID: 18955686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodegenerative illness in transgenic mice expressing a transmembrane form of the prion protein.
    Stewart RS; Piccardo P; Ghetti B; Harris DA
    J Neurosci; 2005 Mar; 25(13):3469-77. PubMed ID: 15800202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominant-negative inhibition of prion replication in transgenic mice.
    Perrier V; Kaneko K; Safar J; Vergara J; Tremblay P; DeArmond SJ; Cohen FE; Prusiner SB; Wallace AC
    Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13079-84. PubMed ID: 12271119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and infectious prion diseases.
    Prusiner SB
    Arch Neurol; 1993 Nov; 50(11):1129-53. PubMed ID: 8105771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards authentic transgenic mouse models of heritable PrP prion diseases.
    Watts JC; Giles K; Bourkas ME; Patel S; Oehler A; Gavidia M; Bhardwaj S; Lee J; Prusiner SB
    Acta Neuropathol; 2016 Oct; 132(4):593-610. PubMed ID: 27350609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PrP knock-out and PrP transgenic mice in prion research.
    Weissmann C; Flechsig E
    Br Med Bull; 2003; 66():43-60. PubMed ID: 14522848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host Determinants of Prion Strain Diversity Independent of Prion Protein Genotype.
    Crowell J; Hughson A; Caughey B; Bessen RA
    J Virol; 2015 Oct; 89(20):10427-41. PubMed ID: 26246570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of glycosylation associated with the T183A mutation in human prion disease.
    Grasbon-Frodl E; Lorenz H; Mann U; Nitsch RM; Windl O; Kretzschmar HA
    Acta Neuropathol; 2004 Dec; 108(6):476-84. PubMed ID: 15558291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease-sensitive prions with 144-bp insertion mutations.
    Xiao X; Cali I; Dong Z; Puoti G; Yuan J; Qing L; Wang H; Kong Q; Gambetti P; Zou WQ
    Aging (Albany NY); 2013 Mar; 5(3):155-73. PubMed ID: 23515139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neuropathological phenotype in transgenic mice expressing different prion protein constructs.
    DeArmond SJ; Yang SL; Cayetano-Canlas J; Groth D; Prusiner SB
    Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):415-23. PubMed ID: 7913760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.